latest news releases from the newsroom
The NASDAQ OMX Group, Inc.
Liberty Media Corporation to Join the NASDAQ-100 Index Beginning October 24, 2006
NEW YORK, Oct. 17, 2006 (PRIMEZONE) -- Liberty Media Corporation's Liberty Interactive Series A common stock (Nasdaq:LINTA) of Englewood, Colorado, will become a component of the NASDAQ-100 Index(r) (Nasdaq:NDX) and the NASDAQ-100 Equal Weighted Index (Nasdaq:NDXE) prior to market open on Tuesday, October 24, 2006. Liberty Interactive will replace ATI Technologies Inc. (Nasdaq:ATYT). Liberty Interactive will also be included in the NASDAQ-100 Index Tracking Stock(sm) (Nasdaq:QQQQ).
Enigma Software Group, Inc.
Anti-Spyware Software Developer Enigma Software Group, Inc. Announces Subscriptions for Week Ending October 15, 2006
STAMFORD, Conn., Oct. 17, 2006 (PRIMEZONE) -- Enigma Software Group, Inc. (OTCBB:ENGM) (the "Company"), a technology and services company that creates and develops Internet Privacy Protection and Computer Security Software and Applications for Internet users, today announced 1,415 new subscriptions for the week ending October 15th.
U-Haul International, Inc.
Photo Release -- AMERCO Real Estate Expands U-Haul Self-Storage Operations with the Purchase of Surelock Storage and AAA Sureguard Storage
SARNIA, Ontario, Oct. 17, 2006 (PRIMEZONE) -- AMERCO Real Estate announced today that it has expanded the U-Haul network of self-storage locations with the purchase of Surelock Storage and AAA Sureguard Storage located in Sarnia, Ontario. Surelock Storage, located on 1227 Confederation Street, boasts 240 rooms, with more than 31,000 square feet of storage. AAA Sureguard Storage, located on 1513 Old London Road, boasts 227 rooms, with more than 30,000 square feet of storage. Together, these two new self-storage locations in Sarnia provide a total of 467 storage rooms and 61,000 square feet of storage.
Renasant Corporation Announces Increase in Third Quarter Earnings
TUPELO, Miss., Oct. 17, 2006 (PRIMEZONE) -- Renasant Corporation (Nasdaq:RNST) (the "Company") today announced results for the third quarter of 2006. Basic earnings per share for the third quarter of 2006 were $.43, up 5%, and diluted earnings per share were $.42, up 5%, compared to basic earnings per share of $.41 and diluted earnings per share of $.40, respectively, for the third quarter of 2005. Net income for the third quarter of 2006 was $6,632,000, up 5%, or $307,000, from the third quarter of 2005. Prior period per share amounts have been restated for the 3 for 2 stock split issued during the third quarter of 2006.
Lincoln Bancorp Announces Third Quarter Earnings
PLAINFIELD, Ind., Oct. 17, 2006 (PRIMEZONE) -- Lincoln Bancorp (Nasdaq:LNCB) (the "Company"), the holding company of Lincoln Bank (the "Bank"), announced today that net income for the third quarter ended September 30, 2006 was $840,000 or $.17 basic earnings per share and $.16 diluted earnings per share. This compared to net income of $1,215,000 for the third quarter of 2005 or $.24 for both basic and diluted income per share.
NowAuto Group, Inc.
NowAuto Group, Inc. Announces Fiscal Year End Results
TEMPE, Ariz., Oct. 17, 2006 (PRIMEZONE) -- NowAuto Group, Inc. (OTCBB:NAUG) today announced results of its fiscal 2006 year. The Company reported revenue of $11.68 million, up from $2.09 million in the prior year, and Net Income before impairment of $0.02 per diluted share versus a net Loss of $0.15 per diluted share in the prior year.
Independent Results Support the Use of BioCurex Technology for Gastric Cancer
RICHMOND, British Columbia, Oct. 17, 2006 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announced today that a group of scientists led by Dr. So Tsuboi from the Shigei Medical Research Hospital, Japan, have published results on the expression of the receptor for AFP (RECAF) in normal, benign and malignant stomach tissue. The tissue study used a variation of the Company's Histo-RECAF kit. The results indicate that RECAF was expressed in 34 out of 47 cancers and not expressed in 59 out of 61 normal or benign tissues. The authors conclude that RECAF may become a new clinically useful marker of gastric cancer.